Science Corp isn't diving into brain surgery just for the thrill. The company plans to place a tiny sensor on a human brain during an already scheduled operation. The 520-electrode chip, no bigger than a pea, will rest on the brain's surface, recording activity without digging deep. This isn't a sci
A prominent figure in the biotech world has raised a red flag. Noubar Afeyan, a well-known investor, has expressed concerns about a growing resistance to science in the United States. He believes this trend could have serious consequences. In a recent letter to investors, Afeyan warned that rejecti
Lilly, a big name in medicine, is making a big move. They're buying Ventyx, a smaller company with a promising lineup of drugs. Ventyx's focus? Inflammation. They're working on small molecules that could treat a wide range of diseases caused by chronic inflammation. Think heart disease, brain disord
The world of diabetes treatment is buzzing with fresh insights, thanks to a recent presentation and interview by Dr. Ralph DeFronzo. He's a big shot in the field, known for his work at UT Health San Antonio. The focus? Icovamenib, a drug that's showing promise in helping people with diabetes. Dr. D
In the fast-paced world of biotech, making decisions can feel like navigating a battlefield. David Esposito, a seasoned leader in this field, knows this all too well. His background as an infantry officer in the U. S. Army's 101st Airborne Division has shaped his approach to leadership. He believes
The world of biotech is changing fast, and the US is falling behind. For years, the US has been the go-to place for biotech and pharmaceutical breakthroughs. However, China is rapidly catching up, and it's not because of some secret formula. The US is slowing itself down with too many rules and red
